 Life Science Investor Mandates
(Feb. 8 - Feb. 14
)
|
|
|
|
|
Seek Life Sciences Technologies of All Stages, With Focus on Specialty Medical Devices
|
|
Broadly Seeking Life Science Opportunities in USA & Europe, with Focus on Pre-Clinical Therapeutic Assets
|
|
Invests in USA & Canada Life Sciences Technologies, Open to All Sectors and Stages of Development
|
|
Looks for Medtech and Digital Health Companies in USA and Canada, with Focus on Drug Platform & Consumer-Facing Technologies
|
|
Click to see investors that are a fit for your product and stage of development
|
|
Click here if you are a service provider and want to see a list of funded life science companies that are a fit for you
|
|
Click here if you want to receive free, targeted early stage dealflow for your life science investment firm
|
|
 |
|
 |
|
|
By
Dennis Ford, Founder & CEO, Life Science Nation; Creator of RESI Conference Series
RESI takes place every few months and is a "rolling" ongoing conference series that provides a vehicle to regularly meet with potential partners. No other conference provider has instituted this kind of format. Most conferences are either annual or bi-annual. At RESI, the two main constituencies - scientist/entrepreneurs and investors/strategic partners - have an ongoing opportunity to connect based on fit (i.e. type of product, stage of company, size of raise and other criteria), create a dialogue that grows into a relationship and eventual partnership. LSN has found that having a conference series where buyer and seller can easily meet and follow up every few months greatly aids the building-a-relationship process.
The state of the partnering-conference model that LSN saw when we launched RESI was mostly content-based informational conferences with a partnering software program you could use to set up meetings.
LSN added a matching module for the pairing-up of profiles of the early stage buy-side and sell-side players. RESI is a relationship-based partnering conference and not a content-based informational conference. There is a huge difference in the two models...
|
|
RESI is headed to MaRS in Toronto for the third time. Our annual visits to the city have allowed LSN to take the pulse of Canadian life science, and we have seen Canada go from strength to strength over the years and attract an increasing amount of investment interest. Taking a look at a sample of startup data from the LSN Company Platform, we can examine life science trends in Canada.
While every region of Canada is home to some life science startup activity, the main hubs are in Ontario, Quebec and British Columbia. Let's see how the different verticals within life science and health innovation are represented in those three hubs. From our sample, we took a look at early stage therapeutic companies (Preclinical through Phase II), development-stage medical technology companies, and all digital health companies...
|
|
At the 13th Annual Non-Dilutive Funding Summit on January 10th during JPM, Life Science Nation (LSN)'s Founder & CEO, Dennis Ford presented to an audience of actively fundraising, early-stage life science entrepreneurs. "The 10 Myths of Fundraising" session helped provide fundamental context on the daunting fundraising process, from proper branding & messaging to creating a Global Target List (GTL) of investors and how to utilize these materials for a successful fundraising campaign. Most importantly, the session walked through the top 10 myths in fundraising, uncovering the truth to these common misconceptions and providing realistic insights that every fundraising CEO should know.
For those who missed out, we are happy to be able to provide a video of this presentation! If you are interested in delving into the topics covered in the video and beyond, be sure to take a look at Dennis's book, The Life Science Executive's Fundraising Manifesto.
|
|
|
Created & Produced by
|
 |
|
|
|
